TrialNature communications2026

Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trial.

Isabelle Ray-Coquard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.